✦ LIBER ✦

Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network

✍ Scribed by Rachel A. Freedman; Melissa E. Hughes; Rebecca A. Ottesen; Jane C. Weeks; Yulei He; Yu-Ning Wong; Richard Theriault; Nancy L. Keating

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erratum to: Trastuzumab: a review of its

✍ KP Garnock-Jones, GM Keating, LJ Scott 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 49 KB

The Prognostic Significance of Human Epi

✍ D.N. Margalit; J.E. Brock; M. Sreedhara; Y. Chen; P.J. Catalano; P.L. Nguyen; J. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Breast Cancer Subtypes as Defined by the

✍ Carol A. Parise; Katrina R. Bauer; Monica M. Brown; Vincent Caggiano 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

Impact of hormone receptor status on pat

✍ Ines Vaz-Luis, Rebecca A Ottesen, Melissa E Hughes, P Kelly Marcom, Beverly Moy, 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 377 KB

Phase II Study of Neoadjuvant Docetaxel,

✍ Glück, S. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Alterations of the genes involved in the

✍ Mamoru Takada, Toru Higuchi, Katsunori Tozuka, Hiroyuki Takei… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 428 KB